Discovery of PSI-353661, a novel purine nucleotide prodrug for the treatment of HCV infection
Hepatitis C virus afflicts approximately 180 million people worldwide, and the development of direct acting antivirals may offer substantial benefit compared to the current standard of care. Accordingly, prodrugs of 2′-deoxy-2′-fluoro-2′-C-methylguanosine
Chang, Wonsuk,Bao, Donghui,Chun, Byoung-Kwon,Naduthambi, Devan,Nagarathnam, Dhanapalan,Rachakonda, Suguna,Reddy, P. Ganapati,Ross, Bruce S.,Zhang, Hai-Ren,Bansal, Shalini,Espiritu, Christine L.,Keilman, Meg,Lam, Angela M.,Niu, Congrong,Steuer, Holly Micolochick,Furman, Phillip A.,Otto, Michael J.,Sofia, Michael J.
scheme or table
p. 130 - 135
(2011/03/22)
More Articles about upstream products of 1261254-11-8